1. Home
  2. LEA vs GKOS Comparison

LEA vs GKOS Comparison

Compare LEA & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lear Corporation

LEA

Lear Corporation

HOLD

Current Price

$137.87

Market Cap

6.2B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$109.47

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEA
GKOS
Founded
1917
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.3B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
LEA
GKOS
Price
$137.87
$109.47
Analyst Decision
Buy
Strong Buy
Analyst Count
12
14
Target Price
$127.58
$132.00
AVG Volume (30 Days)
656.3K
829.6K
Earning Date
02-04-2026
02-17-2026
Dividend Yield
2.23%
N/A
EPS Growth
N/A
N/A
EPS
8.15
N/A
Revenue
$23,259,100,000.00
$469,820,000.00
Revenue This Year
$1.85
$33.04
Revenue Next Year
$2.72
$22.62
P/E Ratio
$16.92
N/A
Revenue Growth
N/A
30.38
52 Week Low
$73.85
$73.16
52 Week High
$142.84
$161.78

Technical Indicators

Market Signals
Indicator
LEA
GKOS
Relative Strength Index (RSI) 67.95 42.52
Support Level $134.74 $105.37
Resistance Level $142.84 $115.19
Average True Range (ATR) 4.16 5.08
MACD 1.22 -1.55
Stochastic Oscillator 81.65 17.47

Price Performance

Historical Comparison
LEA
GKOS

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: